Good news!

“NSA Ventures has entered into an investment agreement with 3Z ehf. The company aims to market a new method for the pharmaceutical industry to gauge the effectiveness of certain molecules on the central nervous system. The system promises to be more effective and economical than the processes currently in use.”

Read all about it here